Related Experiment Videos
Fatigue after aneurysmal subarachnoid hemorrhage evaluated by pituitary function and 3D-CBF
L Brandt1, H Säveland, S Valdemarsson
1Department of Neurosurgery, University Hospital of Lund, Lund, Sweden. lennart.brandt@neurokir.lu.se
Acta Neurologica Scandinavica
|January 7, 2004
Summary
Aneurysmal subarachnoid hemorrhage (SAH) can cause pituitary dysfunction, potentially contributing to fatigue. While not the sole cause, this endocrine impairment is linked to regional brain damage shown by SPECT scans.
Area of Science:
- Neurology
- Endocrinology
- Radiology
Background:
- Fatigue is a common, yet poorly understood, consequence of aneurysmal subarachnoid hemorrhage (SAH).
- The proximity of supratentorial aneurysms to the hypothalamus and pituitary gland suggests a potential for endocrine dysfunction.
- Investigating pituitary function is crucial for understanding post-SAH fatigue.
Purpose of the Study:
- To investigate the relationship between aneurysmal subarachnoid hemorrhage (SAH) and pituitary function.
- To explore the role of endocrine dysfunction in persistent fatigue following SAH.
- To assess regional cerebral blood flow (CBF) using SPECT in patients with post-SAH fatigue.
Main Methods:
- Evaluated pituitary function in ten patients experiencing fatigue after SAH.
- Utilized 3D-CBF (SPECT) imaging to assess regional brain perfusion.
- Assessed hormonal levels, including gonadotropins and insulin-like growth factor I (IGF-I).
Main Results:
- Pituitary dysfunction was identified in five patients, with gonadotropin disturbances noted in three.
- Mean insulin-like growth factor I (IGF-I) levels were at the lower end of the normal range.
- SPECT revealed pathological changes in the basal region's central structures in patients with endocrine dysfunction.
Conclusions:
- Aneurysmal SAH can lead to partial impairment of pituitary function.
- This pituitary deficit may contribute to, but not fully explain, fatigue after SAH.
- SPECT imaging can identify regional tissue damage associated with pituitary dysfunction post-SAH.